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Abstract 
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serves as a summary of the key aspects of different drugs. The information provided follows the order of 
the outline provided by the National Board of Examiners of Optometry, but the specific details are our 
interpretation of the outline and are not guaranteed to be entirely representative of what will be asked on 
the examination. We hope having pharmacology information summarized in this format will be helpful to 
students. 
Degree Type 
Thesis 
Degree Name 
Master of Science in Vision Science 
Committee Chair 
Dennis L. Smith 
Subject Categories 
Optometry 
This thesis is available at CommonKnowledge: https://commons.pacificu.edu/opt/1471 
Copyright and terms of use 
If you have downloaded this document directly from the web or from CommonKnowledge, see 
the “Rights” section on the previous page for the terms of use. 
If you have received this document through an interlibrary loan/document delivery service, the 
following terms of use apply: 
Copyright in this work is held by the author(s). You may download or print any portion of this 
document for personal use only, or for any use that is allowed by fair use (Title 17, §107 U.S.C.). 
Except for personal or fair use, you or your borrowing library may not reproduce, remix, 
republish, post, transmit, or distribute this document, or any portion thereof, without the 
permission of the copyright owner. [Note: If this document is licensed under a Creative 
Commons license (see “Rights” on the previous page) which allows broader usage rights, your 
use is governed by the terms of that license.] 
Inquiries regarding further use of these materials should be addressed to: CommonKnowledge 
Rights, Pacific University Library, 2043 College Way, Forest Grove, OR 97116, (503) 352-7209. 
Email inquiries may be directed to:.copyright@pacificu.edu 
NBEO PHARMACOLOGY REVIEW GUIDE 
By: 
Karen K. Chow, B.S. 
Robyn N. Clausen, B.S. 
A thesis submitted to the faculty of the 
College of Optometry 
Pacific University 
Forest Grove, Oregon 
For the degree of 
Doctor of Optometry 
April, 2004 
Faculty Advisor: Dennis L. Smith, O,D,, M.S., F.A,A.O. 
PACIFIC UNrVERSlTY LIBHHKY 
FOREST GROVE. OREGON 
Authors: 
Karen Chow 
~kn'nis  Smith, O.D., M.S., F.A.A.O. 
Biographies: 
Karen K. Chow is currently working towards her doctorate of optometry degree at Pacific 
University College of Optometry and anticipates graduating from the program in May, 
2005. Prior to attending Pacific University, Karen earned a Bachelor of Science degree 
in Molecular Cell Biology at University of Arizona, Tucson. 
Robyn N. Clausen is currently working towards her doctorate of optometry degree at 
Pacific University College of Optometry and anticipates graduating from the program in 
May, 2005. Prior to attenhng Pacific University, Robyn attended South Dakota State 
University, where she earned a Bachelor of Science degree in Biology. 
iii 
Abstract: 
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pharmacology section of the National Board Exam (Part I). We have compiled 
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provided by the National Board of Examiners of Optometry, but the specific details are 
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QDRENGERGIC AGONISTS 
Vlechanism: Increase level of sympathetic activity by directly and/or indirectly stimulating adrenergic receptors. 
Direct-acting: Agents that act directly on the postsynaptic adrenergic receptors to produce the same effect as natural 
stimulation of the receptors 
Indirect-acting: Agents that cause an increase in norepinephrine release from presynaptic neurons, and therefore indirectly increase 
the level of sympathetic activity 
Mixed action: Agents that cause an increase in norepinephrine release from presynaptic neurons as well as activating adrenergic 
receptors of postsynaptic neurons 
Specific classes include catecholamines and non-catecholamines 3 
Catecholamine characteristics: -Contain a 3,4-dihydroxybenzene group 
-Greater potential in alpha and beta receptor activation than non-catecholamines 
-Not effective when given orally because of rapid inactivation by catechol-0-methyl 
transferase (COMT) and monoamine oxidase (MAO) 
-Poor CNS penetration due to polar nature 
Non-catecholarnine characteristics: -Do not contain a 3,4-dihydroxybenzene group 
-Not inactivated by COMT, and less inactivation by MA0 than catecholamines, resulting 
in longer duration of action 
-Effective in oral administration 
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4DRENERGIC ANTAGONISTS 
Mechanism: Decrease the amount of sympathetic activity by either binding to and blocking adrenergic receptors or affecting release (andlor 
re-uptake) of neurotransmitter from the presynaptic neuron 
presynaptic neuron 
from entering storage 
CHOLINERGIC AGONISTS 
aechanism: Increase level of parasympathetic activity by directly or indirectly activating cholinergic receptors 
Direct-acting: Agents that act directly on the postsynaptic cholinergic receptors to produce the same effect as natural 
stimulation of the receptors (M = muscarinic receptors, N = nicotinic receptors) 
Indirect-acting: Indirectly cause stimulation of cholinergic neurons by inhibiting acetylcholinesterase and thereby prolonging 
the effectiveness of acetylcholine in the synaptic cleft (cholinesterase inhibitors) 
Drugs Mechanism Receptors Indications 
Affected 
Acetylcholine Not used therapeutically because of wide range of action and rapid 
inactivation by acetylcholinesterase 
Bethanechol 
Carbachol 
Pilocarpine 
Edrophonium 
Neostigrnine 
Physostigrnine 
Pyridostigrnine 
Isoflurophate 
Direct-acting 
Direct-acting 
Direct-acting 
Reversible 
indirect-acting 
Reversible 
indirect-acting 
Reversible 
indirect-acting 
Reversible 
indirect-acting 
--- 
Irreversible 
indirect-acting 
M 
N 
M 
Stimulation of atonic bladder in postpartum or postoperative nonobstructive 
urinary retention 
Miosis, lowering intraocular pressure (rarely used) 
Emergency lowering of intraocular pressure 
Diagnosis of myasthenia gravis 
Symptomatic treatment of myasthenia gravis, stimulates bladder and GI tract, 
antidote for tubocurarine 
Intestinal and bladder immotility, miosis, intraocular pressure reduction 
Symptomatic treatment of myasthenia gravis 
Open-angle glaucoma 
CHOLINERGIC ANTAGONISTSIGANGLIONIC BLOCKERS 
3holinergic antagonists are also called cholinergic blockers or anticholinergic drugs 
vlechanism: -Antimuscarinic agents compete with acetylcholine for muscarinic receptors. As a result, these agents decrease 
parasympathetic activity. 
-Ganglionic agents act on nicotinic receptors to block the entire output of the autonomic nervous system. The application of 
these agents are limited to experimental uses. 
Dru s Mechanism 
Antimuscarinic agents 
Mydriasis, cycloplegia, reduction of 
gastrointestinal activity, enuresis, 
organophosphate poisoning, and 
generalized reduction of bodily 
secretions 
Motion sickness 
(Amnesia and sedation with concurrent 
use of morphine) 
Chronic obstructive pulmonary disease 
Emergency use for lowering blood 
pressure (in pulmonary edema or 
Atropine 
Scopolamine 
Ipratropium 
-High dosages: tachycardia 
I -Low dosages: bradycardia 
-CNS effects: restlessness, 
' confusion, hallucinations, 
delirium 
-Others: dry mouth, blurred 
vision, constipation 
-Similar to atropine 
No known side effects 
-Many including CNS 
disturbances 
-Blocks central and peripheral 
muscarinic receptors 
-More potent and longer acting 
on the CNS than atropine 
-Similar to atropine but slower 
onset 
Ganglionic blockers 
Nicotine 
Trimethaphan 
I 
-Low dosages: ganglionic 
stimulation (parasympathetic- 
like effects) 
-High dosages: ganglionic 
inhibition (sympathetic-like 
effects) 
-Competitive, short-acting 
ganglionic agent 
VEUROMUSCULAR TRANSMISSION AGONISTS AND ANTAGONISTS 
Category Drugs Mechanism 
Neuromuscular 
transmission 
agonists 
-Causes depolarization at 
neuromuscular junction 
(nicotinic receptors) 
-Initially, there is a transient 
twitching of the muscles as the 
sodium channels open. This 
continuous depolarization slows 
and even prevents repolarization 
-Succinylcholine 
Indications 
Neuromuscular -Mivacurium -Low doses: combine with 
transmission -Atracurium nicotinic receptor to prevent during surgery 
PrecautionsISide Effects 
Rapid endotracheal 
antagonists 
-Hyperthermia 
-Tubocurarine 
-Metocurine 
-Doxacurium 
-Rocuronium 
-Vecuronium 
-Pipercuronium 
-Pancuronium 
-Succinylcholine 
intubation at the start of 
anesthesia administration 
-Apnea 
ACh from binding (reversible) 
3 prevent depolarization of the 
muscle cell membrane and 
inhibit muscular contraction 
-High does: block ion channels 
of motor end-plates on muscle 
cells 
-Increased intraocular pressure 
-Hyperkalemia 
-Malignant hyperthennia 
%UTACOID AGONEST'S 
iutacoids are chemicals formed by a tissue that act on that same tissue (function as local hormones). 
Naturally occurring autacoids include prostaglandins, histamine, and serotonin 
Xxmples of prostaglandins used therapeutically: 
Drags 
Dinoprost 
Indication 
Abortion 
Carboprost Abortion 
Dionoprostone 
Misoprosto1 (in combination 
with Methotrexate) 
Misoprosto[ 
Alprostadil 
Abortion 
Abortion 
Inhibiting secretion of HCI in peptic ulcers 
Male impotence 
QUTACOID ANTAGONISTS 
HI-Histamine receptor First generation agents Block histamine -Drugs of choice for -Acute poisoning in 
blockers -Alkylamines release at receptor allergic rhinitis and young children 
-Ethanolamines, site urticaria common in high doses 
-Ethylenediamines, -Motion sickness -Sedation/fatigue 
-Phenothiazines, -Insomnia -Tinnitus 
-Piperazines, -Dizziness 
-Piperidines -Blurred vision, 
Second generation agents -Dry mouth 
-Fexofenadine -Frequent urination 
-Astemazole -Possible cardiac 
-Loratadine arrhythmias with 
-Cetirizine concurrent use of 
-Drug interaction with 
alcohol, monoamine 
oxidase inhibitors 
Prevent stimulation -Peptic ulcers -CNS and GI 
of H2 receptors in -Zollinger-Ellison disturbances 
stomach + decrease syndrome -Inhibition of P450 
gastric acid secretion -Acute stress ulcers system 
-Gastroesophageal 
BRONCHODILATORS 
3oal: To achieve bronchodilation by sympathetic activation or parsympathetic inhibition 
Epinephrine 
Isoproterenol 
Metaproterenol 
Terbutaline 
Albuterol 
Ipratropium 
bromide 
Theophylline 
Mechanism Location of PrecautionsISide Effects Indications 
Response 
p2 stimulation Bronchial smooth CNS disturbances, -Allergic or histamine induced 
muscle hemorrhage, cardiac bronchoconstriction 
p2 stimulation Bronchial smooth 1 
muscle 
Pz-selective Bronchial smooth Similar to epinephrine 
muscle 
- --
Pz-selective Bronchial smooth Similar to epinephrine 
1 (short acting) muscle 
Pz-selective Bronchial smooth Similar to epinephrine -Bronchospasm 
Competitively 
inhibits action of 
ACh at the 
muscarinic 
receptors in airway 
Unknown 
muscle 
1 Blocks vagus input to 
lungs 
Bronchial smooth 
muscle 
- -
Cough, drying of 
oropharynx, headache, 
dizziness, upper 
respiratiory infections, 
bronchitis, blurred vision, 
hypersensitivity 
CNS, GI, and GU 
disturbances, 
hyperglycemia, 
hypokalemia 
-Use for patients with intolerance to 
adrenergic agonists 
-Long-term control asthma treatment 
MAST CELL STABILIZERS AND MUCOLYTIC AGENTS 
dast cell stabilizers are used prevent degranulation of mast cells in order to prevent inflammation of the respiratory airways. 
3ecause of their hlgh safety profile, mast cell stabilizers are often considered a safe drug choice for children and pregnant women. 
ducolytic agents are used to liquefy or reduce viscosity of respiratory secretions. 
Drugs 
Mast cell stabilizers 
Cromolyn, Nedocromil 
N-Acetylcysteine -Cleaves protein complexes in mucus Chronic bronchopulmonary -Wheeze 
(Mucomy st) disease -Difficulty breathing 
-Clammy skin 
-Slun rash 
I -Fever I 
Indications 
Asthma 
Mechanism 
-Block early phase pulmonary 
inflammation through inhibition of 
chloride channels of mast cells 
-Block late phase pulmonary inflammation 
through inhibition of chloride channels of 
eosinophils 
- 
PrecautionsISide Effects 
- 
-Nausea 
-Headache 
-Unpleasant taste 
-Cough* 
-Wheeze* 
-Tightness of chest* 
*Side effects can be prevented 
if patient uses a p2 agonist 
Mucoly tic agents 
Cystic fibrosis Dornase Alfa (DNase) 
(Pulmozyme) 
-Voice changes 
-Sore throat 
-Skin rash 
-Conjunctivitis 
-Cleaves DNA strands in the respiratory 
secretions (the viscosity of the secretions 
is due to DNA from lysed inflammatory 
cells) 
GASTROINTESTINAL AGENTS - TREATING PEPTIC ULCER DISEASE 
Category Drugs Mechanism Indications Precautions/Side Effects 
Prevent stimulation of Hz -CNS and GI disturbances 
Inhibit HCl secretion and 
promote mucous and (stimulate uterine contractions) 
bicarbonate secretion 
(cy toprotective effect) 
Proton pump 
inhibitors 
-0meprazole 
-Lansoprazole 
Irreversibly inhibit enzymes 
that stimulate HC1 secretion 
I 
Antimuscarinics 
Antacids 
Mucosal Protective 
Agents 
Prevent parasympathetic 
stimulation of acid production 
in stomach 
ppp
Neutralize excess acid in 
stomach 
Promote mucous secretion in 
stomach 
-Hyoscyamine 
-Mepenzolate 
-Piremepine 
-Aluminum 
hydroxide 
-Calcium carbonate 
-Magnesium 
hydroxide 
-Sodium bicarbonate 
ppp
-Sucralfate 
-Colloidal bismuth 
-Peptic and gastric ulcers 
-Zollinger-Ellison syndrome 
-Erosive esophagitis 
-CNS disturbances 
-Potentially fatal toxic epidermal 
necrolysis with omeprazole use (but 
-Peptic ulcers 
-Zollinger-Ellison syndrome 
rare) 
-Reduced acid levels in stomach 
(achlorhy dria) 
-Effects of suppressed 
parasympathetic activity 
-Peptic ulcers -GI disturbances 
-Caution in patients with congestive 
heart failure or hypertension 
(affects sodium levels) 
-Gastric ulcers 
-Reducing mucosal 
inflammation and preventing 
injury 
-Very well tolerated due to poor 
absorption 
3ASTROINTESTINAL AGENTS - ANTIEMETICS 
'hese agents are used to control nausea and vomiting resulting from chemotherapy 
- -  - 
Class Drugs Mechanism PrecautionsISide Effects 
-Extrapyramidal effects 
-Sedation 
Substituted benzamides -Metoclopromide Prevent vomiting by unknown -Sedation 
mechanism -Diarrhea 
Block dopamine receptors 
B enzodiazepines -Alprazolam Enhance GABA in CNS -Sedation 
-Lorazopam -Anxiolytic effects 
-Amnesia 
Corticosteroids -Dexamethasone 
-Methylprednisolone 
Prevent vomiting by unknown 
mechanism, possibly related to 
prostaglandin inhibition 
Cannabinoids 
5-HT3 serotonin receptor 
blockers 
-Not for use in immunocompromised I 
-Gushing's syndrome 
-Increased intraocular pressure 
Prevent vomiting by unknown 
mechanism 
Selectively inhibit activation of 5- 
HT3 receptors 
-Dronabinol 
-Nabilone 
-Granisetron 
-0ndansetron 
-CNS disturbances 
-Headaches 
3ASTROINTESTINAL AGENTS - ANTIDIARRHEALS AND LAXATIVES 
PrecautionsISide Effects Mechanism Category Drugs 
Antidiarrheals 
Antimotility agents 
Adsorbents 
Fluid and electrolyte 
transport modifiers 
Laxatives 
Irritants and 
stimulants 
Bulking agents 
-CNS and GI disturbances 
-Toxic megacolon 
-Not for use in young children 
-Not for use in patients with severe colitis 
-Diphenoxylate 
-Loperamide 
-Inhibit acetylcholine release 3 
decrease peristalsis 
-Kaolin 
-Pectin 
-Methylcellulose 
-Activated attapulgite 
-Magnesium aluminum 
silicate 
-Adsorb intestinal toxins or intestinal 
microorganisms 
-Interfere with absorption of other drugs 
-Aspirin 
-1ndomethacin 
-Bismuth subsalicylate 
-Castor oil 
-Cascara (contains emodin) 
-Senna (contains emodin) 
-Aloe (contains emodin) 
-Pheolphtalein 
-Bisacodyl 
-Inhibit prostaglandin synthesis 
-Reduce fluid secretions in bowel 
-Effects of reduced prostaglandin levels 
-Increase gut motility -Abdominal cramps 
-Atonic colon with prolonged use 
-Emodin can enter breast milk 
-Increase motility when indigestible 
material interacts with water and 
prevents water absorption 
-GI disturbances 
iNTIBIOTICS: PENICILLINS 
Jategory: Bactericidal beta-lactam antibiotic 
dechanism: prevents bacterial cell wall synthesis by inhibiting peptide bond formation in peptidoglycan 
'enicillins all have the same general structure o II ontaining a beta-lactam ring (shown in red), iz-t -NH-C 1 4 14 
fut have varying side chains (shown in blue). 
PrecautionslSide Effects P-Lactamase ResiglIincc Cafegory 
Nntural Penicillins 
Penicillin G 
Penicillin V 
Drugs Spectrum of Activity 
Penicillin G 
SmnE-Synthetic Penicillins 
No 
I 
-Gram p&itivc (like Staph. and Strep.) 
-Anaerobic bacterial (above the 
diaphragm) 
-Some Gram negative (like N. 
gonorrhoeae, N. meningitides, and 
Shigella) 
-Not acid stable (must bc injected) 
-Cross hypersensitivity with cephalosporins 
-Jarisch-Herxheimer reaction 
-Hypernatremia 
-Hyperkalemia 
I -Interactions with probenicid, parented 
aminoglycosides, anticoagulants, and 
temcycliocs 
-Similar to penicillin G 
(but is acid stable) 
-  
-Similar to penicillin G 
(but is acid stable) 
-Similar to penicillin G 
(but is acid stable) 
-Gram positive If combined with clavulanate 
-Some Gram negative (better than or sulbactam (to tie up 
enzyme) 
-Limited anaerobes 
-Similar to aminopenicillins If combined with tazobactam 
RniciHin V 
Penicillins 
Penicillinase- 
Resistant Penicillins 
No -Similar to penicillin G -Similar to penicillin G (but is acid stable) 
-Pseudomembranous colitis 
-Interstitial nephritis 
-Interacts with oral contraceptives, probenecid, 
and tetracyclines 
-Mezlocillin 
-Piperacillin 
-Ticarcillin 
-Cloxacillin 
-Dicloxacillin, 
-Nafcillin 
-Methicillin, 
-0xacillin 
-Gram positive only 
or clavulanate (to tie up I 
enzyme) 
Yes 
LNTIBIOTICS: CEPHALOSPORINS 
lactericidal beta-lactam antibiotics 
techanism: Prevent bacterial cell wall synthesis by inhibiting peptide bond formation in peptidoglycan 
:ephalosporins all have the o 
ame general structure 
ontaining a beta-lactam ring (shown in 
:d), but have varying side chains (shown 
1 blue). 
* 
Generation Drugs Spectrum of Activity p-Lacatamase CNS PrecautionsISide Effects 
Resistance Distribution 
-Cephalexin Gram positive > Gram No Poor -Nephrotoxicity 
-Cefadroxil negative -Cross hypersensitivy with 
-Cephradine penicillin 
-Cephalothin -Possible alteration of intestinal 
-Cefaclor  Moderate flora 
-Cefamandole -Interacts with probenicid, 
-Cefonicid the expense of Gram positive aminoglycoside, ethanol 
-Cefoxitin activity (disulfiram-like reaction), and 
-Cefmetazole anticoagulants 
-Cefprozil 
-Cefixime Gram negative > Gram Yes Good 
-Cefpodoxime positive 
-Ceftibuten 
INTIBIOTICS: MACROLIDES 
3acteriostatic antibiotics 
dechanism: Prevent bacterial protein synthesis by binding to 50s subunit of ribosome 
PrecautionsISide Effects 
-Hypersensitivity 
-Pregnancy 
-Caution with liver problems 
-GI disturbances 
-Liver toxicity 
-0totoxicity 
-Inhibits cytochrome P450 enzymes 
-Interacts with carbamazepine, 
theophylline, and warfarin 
-Caution with liver problems 
-Not for use with renal dysfunction 
-Mild GI disturbances 
-Headache and dizziness 
-Rare cholestatic jaundice 
(no effect on P450 enzymes) 
Clarithromycin -Even more effective than -Helicobacter pylori -Pseudomembranous colitis 
erythromycin against Gram -Gram positive bacteria in general -Not approved for children < 6 months 
positive -Not for use during pregnancy or 
nursing 
-Impairment to liver and kidneys 
-Mild GI disturbances 
-Headaches 
-Rash 
(less inhibition of P450 than 
Indications 
-Upper respiratory infections 
-Pneumonia 
-Cellulitis 
-Prophylactic against bacterial 
endocarditis 
-Chlamydia 
-Legionella 
-Diptheria 
-Mycoplasm 
-Moraxella 
-Haemophilus 
-Legionella 
-Nisseria 
-Chlamydia trachomatis, 
-most effective macrolide against 
Drugs Spectrum of Activity 
Erythromycin 
Azy thromycin 
-Gram positive 
-Some Gram negative 
-Less active against Gram 
positive 
-More active against Gram 
negative 
(compared to erythromycin) 
INTIBIOTICS: SULFONAMIDES 
3acteriostatic antibiotics 
dechanism: Halt bacterial growth by blocking folic acid synthesis (structurally similar to PABA - para-aminobenzoic acid) 
;pectrum of Activity: Broad 
, 
PrecautionsISide Effects 
-Cross-sensitivity with carbonic 
anhydrase inhibitors, thiazide 
diuretics, and sulfonylureas 
-Fever 
-Skin rashes 
-Photosensitivity 
-Gastrointestinal disturbances 
-Stevens-Johnson syndrome 
-Crystalluria 
-Hematuria 
-Hemolytic anemia 
-Aplastic anemia 
Sulfasalazine -Ulcerative colitis Not absorbable 
Additional Comments 
Occasionally used in combination with 
Phenazolpyridine or Trimethoprim 
Occasionally combined with Pyrimethamine 
Occasionally combined with Pyrimetharnine 
Drugs 
Sulfamethoxazole 
and 
Sulisoxazole 
Sulfadiazine 
Sulfadozine 
Sodium 
sulfacetamide 
Indications 
-Urinary tract infections 
-Otitis media 
-Chlamydia 
-Pneumoncystis carinii 
-Methicillin resistant S. 
aureus 
-Shigella 
- Salmonella 
-Toxoplasma gondii 
-Malaria 
Used topically in ophthalmic preparations; 
associated with lots of resistance 
INTIBIOTICS: AMINOGLYCOSIDES, CHLORAMPHENICOL, GLYCOPEPTIDES, AND 
LINCOSAMINES 
Spectrum of Activity Frecautions/Side Effects 
-Nephrotoxicity 
-Bind to 30s ribosomal negative enteric -0totoxicity 
subunit of bacteria bacteria -Narrow therapeutic index 
-Not for use during pregnancy 
-Myasthenia gravis 
enhancement 3- 
spectrum; the penicillin 
weakens the wall, 
subunit of bacteria -Thrombocy topenia 
-Liver and kidney impairment 
-GI and CNS disturbances 
-Not for use in infants (gray baby syndrome) 
-Not for use during pregnancy or nursing 
-Bind to peptide side 
chain of N- -Flushing, hypotension and tachycardia with IV 
acetylmuramic acid 
(precursors to bacterial 
- 
Lincosamines -Clindamycin -Bacteriostatic 
-Lincomy cin -Bind to 50s ribosomal -Most anaerobes -GI disturbances 
subunit of bacteria -Enterococci -Pseudomembranous colitis 
-Clostridium -Stevens-Johnson syndrome 
4NTIBIOTICS: POLYMIXINS, QUINOLONES, TETRACYCLINES, AND 
r RIMETHOPRIM 
Category Drugs Mechanism 
-Disrupt cell membranes 
Quinolones -Ciprofloxacin -Fatal anaphylactic reactions I 
-Enoxacin -Block DNA replication by -GI and CNS disturbances 
-Lomefloxacin interfering with DNA gyrase -Increased intracranial pressure 
-Norfloxacin 
-0floxacin 
-Cinoxacin -Tendon and joint ruptures 
Tetracyclines 
Trimethoprim 
Low-lipid-solubility 
-0xy tetracy cline 
Intermediate-lipid- 
solubility 
-Tetracycline 
-Demeclocy cline 
High-lipid-solubility 
-Doxycy cline 
-Minocycline 
-Trimethoprim 
-Bacteriostatic 
-Prevent bacterial protein synthesis 
by binding to 30s ribosomal subunit 
-Broad 
spectrum 
-Renal function impairment 
-Photo toxicity 
-Not for use in children under 8 years 
-Not for use during pregnancy 
-Pseudotumor cerebri 
-Sulfite sensitivity 
-Toxicity occurs in outdated products 
-Interact with antacids, dairy products, iron 
preparations, anticoagulants, cimetidine, digoxin, 
insulin, penicillin, and oral contraceptives 
- 
-Glucose-6-phosphate dehydrogenase (G-6-PD) 
deficiency 
-Impaired liver function 
-Impaired kidney function 
-Megaloblastic anemia 
-Leukopenia and granulocy topenia 
-Not for use during pregnancy 
-Not for use in infants 
-Interacts with methotrexate, sulfonylureas, warfarin, 
-Bacteriostatic 
-Inhibits dihydrofolic acid reductase, 
which inhibits production of 
purines 
1 
-Broad 
spectrum 
Spectrum of Activity/Indications 
- Fungistaticl-cidal 
-Candida 
-Histoplasma 
-Cryptococcus 
-Coccidiodes 
-Aspergillus 
-Blastomyces 
-Fungistatic 
-Chromblastomycosis 
-Candidiasis 
-Cryptococcosis 
-Fungistatic/-cidal 
-Similar toamphotericin B 
-Histoplasmosis 
-Nonmeningeal coccidiomycosis 
and blastomycosis 
-Various dermatophytic infections 
(especially Griseofulvin-resistant 
strains) 
------ 
-Cryptococcus neoformans 
-Candidemia 
-Coccidioidomycosis 
-Blastomycosis 
-Candidasis 
-Histoplasmosis 
-Fungistatic 
-Dermatophytes only (Trichophylon, 
Microsporum, Epidermophyton) 
-- 
-Candida 
Drugs 
Amphotericin 
B (Polyene) 
Flucytosine 
Ketoconazole 
(Imidazole) 
Fluconazole 
(Imidazole) 
Griseofulvin 
Nystatin 
(Polyene 
Resistance 
-Infrequently 
-Associated with decreased 
ergosterol content 
Results with: 
-Decreased levels of enzymes 
needed for conversion of 
5-flucytosine to 5-flurouracil 
-Increased cytosine synthesis 
-None documented 
-HIV-positive patients 
-Due to lack of energy-dependent 
Mechanism 
Disrupts membrane 
function by binding to 
ergosterol 
Disrupts DNA synthesis 
via cytosine-specific 
permease 
Blocks demethylation 
of lanosterol 
(cytochrome P450 
enzyme) 
Similar to ketoconazole 
-  
Inhibits fungal mitosis 
(energy-dependent 
process) 
Similar to amphotericin 
B 
]I Precautions/Side Effects 
-Fever 
-Chills 
-Renal impairment 
-Hypotension 
-Anemia 
-Neurological effects 
-Thrombophlebitis 
-Hematologic toxicity 
-Hepatic dysfunction 
-GI disturbances 
-GI disturbances 
-Endocrine effects 
-Hepatic dysfunctions 
-GI disturbances 
-Rash 
-Hepatitis (rare) 
-Not for use in pregnancy 
(teratogenic) 
-Hypersensitivity 
uptake system -Hepatotoxicity 
-Rare (topical use only) 
INTIPARASITIC DRUGS 
vlechanism: -The mechanism of many of these agents is not completely understood. 
-Most of the protozoal agents are presumed to interfere with biosynthetic pathways of the parasite. 
-Most of the helminthic agents are presumed to interfere with the neuromuscular function of the worms. 
Indications Drugs 
-Intestinal protozoa -1odoquinol 
-Nitroimidazoles (metronidazole) 
-Quinacrine 
-Toxoplasmosis 
-Malaria 
-Trypanosomes 
-Leishmaniasis 
-Intestinal 
-Tissue helrninths 
-Pyrimethamine 
("classic triple therapy" containing pyrimethamine, sulfadiazine, and corticosteroids) 
-Folate antagonists (pyrimethamine, sulfanamide) 
-Quinolones (chloroquine, mefloquine, primaquine, quinine) 
-Eflornithine 
-Heavy metals (melarsoprol, sodium stibogluconate, meglumine antimonite) 
-Nitrofurtimox 
-Avermectins (ivermectin) 
-Benzimidazoles (mebendazole, thiabendazole, albendazole) 
-Phenols (niclosamide) 
-Piperazines (peperazine, diethylcarbamazine) 
-Pyrazinoisoquinolines (praziquantel) 
- 
INTIVIRAL AGENTS 
Drugs against retroviral infections (human immunodeficiency virus) 
Reverse transcriptase I -Zidovudine I Halt DNA replication by 1 -Anemia 
Category Drugs Mechanism PrecautionsISide Effects 
Drugs against respiratory 
viral infections 
Drugs against herpes and 
cytomegalovirus 
infections 
inhibitors (nucleiside 
analogs) 
 
Protease inhibitors 1 -1ndinavir I Inhibit HIV-1 protease 3 1 -P450 inhibition 
-Amantadine 
-Ribavirin 
-Rimantadhe 
-Acyclovir 
-Cidofovir 
-Famciclovir 
-Foscarnet 
-Ganciclovir 
-Penciclovir 
-Trifluridine 
-Didanosine 
-Lamivudine 
-Stavudine 
-Zalcitabine 
incorporating into growing 
viral DNA chain 
1 
produce nonfunctional virus -Hyperglycemia 
particles -Hyperbilirubinemia 
-Leukopenia 
-Headaches 
-Seizures 
-Pancreatitis 
-Peripheral neuropathy 
Mechanism unclear 
(possibly prevent viral entry 
into cells) 
Inhibit viral DNA synthesis 
-CNS disturbances 
-Use with caution during pregnancy and nursing 
-Transient anemia with ribavirin 
-Headaches 
-GI disturbances 
-Use with caution during pregnancy and nursing 
-Renal precipitation in dehydrated patients 
I 
1NTINEOPLASTIC AGENTS 
Category Drugs Indications PrecautionsISide Effects 
- 
Antimetabolites 
' 
-Methotrexate -Acute lymphocytic leukemia -Hypersensitivity reactions 
-Choriocarcinoma -GI disturbances 
These agents interfere with -Burkitt's lymphoma -Kidney and liver dysfunction 
availability of nucleotides + -Breast cancer -Pulmonary toxicity 
inhibit DNARNA synthesis -Headheck carcinomas -Neurologic toxicitiy 
-Not for use during pregnancy 
-6-Mercaptopurine -Maintenance of remission in -Bone marrow suppression 
acute lymphoblastic leukemia -Liver dysfunction 
-Bone marrow suppression 
-Liver damage 
-5-Huorouracil -Slowly growing, solid tumors -GI disturbances 
-Alopecia 
-Ulceration of mucous membranes 
-Bone marrow suppression 
-Acute myelogenous leukemia -GI disturbances 
I -Granulocytopenia 
-Liver dysfunction 
-CNS disturbances with high doses 
-Fludarabine -Chronic lymphocytic leukemia -GI disturbances 
-Hairy cell leukemia -Fever 
-Edema 
Alkylating agents -Mechlorethamine -Hodgkin's disease -GI disturbances 
-Bone marrow suppression 
These agents alkylate 
(covalently bond to) DNA 
-Cyclophosphamide 
-1fosfamide 
-Nitrosureas 
-Burkitt's lymphoma 
-Breast cancer 
-Nephroitic syndrome 
-Rheumatoid arthritis 
-GI disturbances 
-Alopecia 
-Bone marrow suppression 
-Neurotoxicity 
-Fibrosis of bladder 
-Amenorrhea 
-Testicular atrophy and sterility 
-Brain tumors (able to enter CNS) -Aplastic anemia 
-Renal toxicity 
-Pulmonary fibrosis 
4NTINEOPLASTIC AGENTS continued 
Precautions/Side Effects 
-GI disturbances 
-Bone marrow suppression 
-Stomatitis 
-Alopecia 
-Similar to dactinomycin 
-Irreversible cardiotoxicity 
-Similar to doxorubicin 
Category 
Antibiotics 
These agents interact with 
and disrupt the function of 
DNA 
Microtubule inhibitors 
These agents bind to tubulin 
+ block metaphase of 
mitosis 
Drugs 
-Dactinomycin 
-Doxorubicin 
-Daunorubicin 
Indications 
-
-Wilm's tumor 
-Gestational choriocarcinoma 
-Soft-tissue carcinomas 
-Sarcomas 
-Carcinomas 
-Lymphocytic leukemia 
-Lymphomas 
-Acute lymphocytic leukemia 
-Bleomy cin -Testicular tumors -Pulmonary toxicity 
-Squamous cell carcinomas -Hyperpigmentation of skin 
-Lymphomas -Fever and chills 
-Mucocutaneous reactions 
-Alopecia 
-Vincristine -Acute lymphoblas~ic leukemia in -GI disturbances 
children -Alopecia 
-Wilm' s tumor -Peripheral neuropathy 
-Ewing's soft-tissue sarcoma 
-Hodgkin's lymphoma 
-Vinblastine 
-Paclitaxel 
-Non-Hodgkin's lymphoma 
-Metastatic testicular carcinoma 
-Hodgkin' s lymphoma 
-Non-Hodgkin's lymphoma 
-Advanced ovarian cancer 
-Metastatic breast cancer 
-Small-cell lung cancer 
-Squamous cell carcinoma 
-GI disturbances 
-Alopecia 
-Bone marrow suppression 
-Alopecia 
-Hypersensitivity 
-Neutropenia 
-Peripheral neuropathy 
-Bradycardia 
INTINEOPLASTIC AGENTS continued 
Category 
Steroid hormone analogs 
These agents act as hormone 
agonists to treat hormone- 
responsive tumors 
I 
Steroid hormone antagonists 
These agents cause tumor 
regression in hormone- 
dependent tumors 
Drugs 
-Prednisone 
-Ethinyl estradiol 
(estrogen) 
-Leuprolide 
(gonadotropin- 
releasing hormone 
analog) 
-Tomoxifen 
(estrogen antagonist) 
-Flutamide 
(androgen antagonist) 
-Aminoglutethimide 
(estrogen antagonist) 
Indications 
-Acute lymphocy tic leukemia 
-HodgkinYs lymphoma 
-Non-Hodgkin's lymphoma 
-Prostate cancer 
-Prostate cancer 
-Estrogen-dependent breast 
cancer 
-Prostate cancer 
. 
-Metastatic breast cancer 
Precautions/Side Effects 
-Increased intraocular pressure 
-Osteoporosis 
-Immunosuppression 
-Increased appetite 
-Hypertension 
-Edema 
-Peptic ulcers 
-Thromboemboli 
-Myocardial infarction 
-Stroke 
-Hypercalcemia 
-Dysmenorrhea 
-Genecomastia 
-Impotence 
-Hot flashes 
-Tumor flare 
-Hot flashes 
-GI disturbances 
-Rash 
-Vaginal bleeding 
-Hypercalcemia 
-Endometrial cancer 
-Gynecomastia 
-GI disturbances 
-CNS depression 
-Rash 
[MMUNOSUPPRESSANTS 
Category Drugs Mechanism Indications PrecautionsISide Effects 
Antibodies 
-Fever and chills 
-Thrombocytopenia 
-Leukopenia 
-Infections 
-CNS disturbances 
Non-selective 
immunosuppressants 
Selective 
immunosuppressants 
-Azathioprine 
-Mycophenolate mofetil 
-Cyclosporine 
-Tacrolimus (a macrolide 
antibiotic) 
Interfere with nucleic acid 
metabolism, which is 
required for lymphocyte 
proliferation 
-Rheumatoid arthritis 
-Systemic lupus 
erythematosus 
-Bone marrow 
suppression 
-Infections 
-Liver toxicity 
-Lymphoma 
-Nephrotoxicity 
-Liver toxicity 
-Alteration in lipid levels 
-Hyperglycemia 
-Hirsutism 
-Lymphoma 
I 
Inhibit production of 
factors needed for T cell 
growth 
-Uveitis 
-Type 1 diabetes mellitus 
-Asthma 
-Grave's disease 
-Rheumatoid arthritis 
-Psoriasis 
-Corneal transplants 
-Transplants 
STEROIDAL ANTI-INFLAMMATORY AGENTS 
:orticosteroids prevent the formation of arachidonic acid metabolites. Both the lipoxygenase pathway (which produces leukotrienes) and the 
yclooxygenase pathway (which produces thromboxane A2 and prostaglandins) are blocked. 
Drugs Mechanism Indications PrecautionsISide effects 
-Addison's disease -Decreased bone mass 
-Cortisol -Adrenocorticotropic hormone (ACTH) -Interference with wound healing 
-Cortisone insufficiency -Hypertension 
-Prednisone intracellular receptors -Corticotropin-releasing factor (CRF) -Edema 
-Prednisolone insufficiency -Peptic ulcers 
-MethylpminisoIone -Hypothalamic-pituitary adrenal (HPA) 
, 
-CNS disturbances 
Intermediate-acting insufficiency -Acute adrenal insufficiency 
-Triamcinolone -Determination of Cushing's syndrome syndrome with abrupt drug 
-Fluprednisolone -Congenital adrenal hyperplasia (CAH) removal 
Long-acting -Inflammation 
-Bethamethasone -Allergies 
-Dexamethasone -Appetite stimulation in patients who 
-Paramethasone have undergone chemotherapy 
VON-STEROIDAL ANTI-INFLAMMATORY AGENTS (NSAIDS) 
JSAIDs are a group of drugs that have anti-inflammatory, antipyretic, and analgesic effects. 
iy inhibiting the cyclooxygenase pathway they prevent the formation of prostaglandins and thromboxane AZ. 
Category I Drugs PrecautionsISide Effects 
Salicylic acids > 
-Hyperventilation and respiratory alkalosis with 
higher doses 
-Sodium Salicylate -Respiratory paralysis and respiratory acidosis at 
-Choline magnesium salicylate toxic doses I 
-Magnesium salicylate -Gastric ulcers 
-GI disturbances 
-Hemorrhage/prolonged bleeding time 
-Sodium and water retention 
-Hyperkalemia 
- 
Indoleacetic acids 
-Acute pancreatitis 
Propionic acids 
Oxicam derivatives 
-Ibuprofen 
-Naproxen 
-Fenoprofen 
-Ketoprofen 
-Flubiprofen 
-0xaprozin 
-Piroxicam 
Reversibly inhibit 
cyclooxy genase 
Mechanism not 
completely understood 
-GI and CNS disturbances 
-GI disturbances 
qEUROTRANSMITTERS OF THE CENTRAL NERVOUS SYSTEM 
Name Neurotransmitter Class Location of Production Function 
Acetylcholine (ACh) Acetylcholine Widespread 
Norepinephrine (NE) 
(catecholamine subgroup) -May facilitate wakefulness/attention 
-May facilitate active (REM) sleep 
-Decreased levels associated with 
Glutamate Afferent neurons 
Gamma-amino -Inhibitory effects 
-- 
Serotonin Biogenic amine 
brainstem 
IPIOID AND NON-OPIOID ANALGESICS 
lechanism: 
bioids Nonovioids 
4ct on p, K, and cr receptors (mainly on p receptors) -Bind to opioid receptors 
:nhibit nerve fring and presynaptic neurotransmitter release -Inhibit re-uptake of serotonin and norepinephrine centrally 
Iecrease pain by inhibiting substance P with its attachment to K receptors 
Drugs I Receptors Affected I Indications I PrecautionsISide Effects I Additional Comments 
Opioids 
-Relieves pain by raising the 
pain threshold at spinal cord 
level 
-Alters brain's perception of 
pain 
-Dysphoria 
-Allergy-induced hypotensive 
effects 
-Elevated intracranial pressure 
-Dependence 
-Sedation 
-Severe respiratory depression 
-GI and GU disturbances 
Morphine 
-Low risk of abuse to morphine) 
-Similar to morphine 
Propoxyphene -p, K. and o -Moderate pain -Dizziness -Weak analgesic (less potent 
(weak agonist) -Sedation than aspirin) 
-Convulsions, CNS depression, 
-p, K, and o 
(full agonist) 
I 
-Severe pain (including 
myocardial infarction) 
coma, and death with high doses 
-Low risk of abuse 
-GI disturbances 
-  
-Dysphoria 
-Similar to morphine 
-No respiratory depression 
-Low risk of abuse 
-Moderate pain via 
receptor activation in 
1 spinal cord 
I -Preoperative medicine 
Non-opfoids 
Trarnadol -p, K, and o -Moderate to severe pain 
Drugs I Mechanism Indications I PrecautionsISide Effects 
Benzodiazepines 
(-am) 
-Anxiety disorders 
-Muscular disorders 
-Seizures 
-Sleep disorders 
-Acute alcohol withdrawal 
syndrome 
-Sedation and amnesia before 
-Enhance GABA receptor 
binding in the CNS which opens 
chloride channels, leading to 
hyperpolarization and decreased 
neuronal firing 
Zolpidem -Acts on a subset of 
benzodiazepine receptors 
-No withdrawal effects and little or 
Buspirone Targets the following specific -Generalized anxiety disorders -Headaches, dizziness, nervousness, 
receptors: lightheadedness 
-5-HTIA serotonin receptors -Low risk of abuse 
-DA2 serotonin receptors -Minimum sedation 
-5-HT2 serotonin receptors 
activity 
-Drowsiness 
-Confusion 
Barbiturates -Interfere with Na+ and K+ 
transport resulting in the 
inhibition of reticular 
activating system 
-Enhance GABA action 
-Anesthesia 
-Anticonvulsant 
-Anxiety 
-CNS disturbances 
-Drug hangover 
-Decreases effectivity of other drugs 
(enzyme induction) 
-Addiction 
-Poisoning (leading cause of death) 
-Respiratory depression 
4NTIPSY CHOTICS 
Category Dm@ Mechanism PrecautionsISide EfPects 
Phenothiasints -Chlorpromazine 
-Fluphenazine 
-Mesoridazine 
-Perphenazint 
-Prochlorperizine 
-Pmrnazine 
-Thioridazine 
-Trifluoperazine 
- 
Complex and not entire1 y 
understood, but the goal is 
general1 y to block duparnine 
I-eceptors 
(Theories suggest that excess 
dopamine leads to many 
psychoses) 
Thixanthenes 
Others 
-Acute dystonia 
-Parkinsonism 
-Malignant syndrome 
-Akathisia 
-Tardive dyskinesia 
-Thiothixene 
-CIozapine 
-Haloper idol 
-Zoxapine 
-Md inrtone 
-0lanaapi ne 
-Pi rnozide 
-Quetiapine 
-Resperidone 
PrecautionsISide Effects 
-Conversion of Ldopa to dopamine in the periphery 3 nausea, vomiting, cardiac 
arrythmias, hypotension 
-Basal ganglionic effects 3 hallucinations and dyskinesia 
-Vitamin Bg enhances Ldopa breakdown 
-Monoamine oxidase (MAO) inhibitors promote catecholamine production 3 
hypertensive crisis 
nrup 
Lcvodopa (L-dopa) 
Mechanism 
Crosses the blood brain barrier as a pro-drug, and 
then transforms into dopamine 
*Effective for reducing rigidity, 
tremors, and other symptoms 
-Glaucoma 3 increased IOP 
-Antipsychotics 3 Parkinson-like symptoms 
Carbidopa 
(dopa decarboxylase 
inhibitor) 
Bromocriptine 
(ergotarnine) 
Amantadine 
(antiviral) 
Co-administered with L-dopa to 
increase the availability of L-dopa in the CNS by 
slowing its breakdown in the periphery 
Dopamine receptor agonist co-administered with 
L-dopa 
(Effective only if patient is L-dopa responsive) 
*Dyskinesia is lessened 
Enhances dopamine availability (Dependent upon 
the integrity of pre-existing dopamine-producing 
-Decreases hypertensive crisis at recommended dosage 
-Hallucinations 
-Confusion 
-Nausea 
-Orthostatic hypotension 
-Worsens symptoms of patients with a previous history of psychosis, vasospasrns, 
peptic ulcers, and myocardial infarctions 
-Acute toxic psychosis with high dosage 
-Less CNS and peripheral side effects than levodopa 
Deprenyl 
I 
cells) 
*More effective on rigidity and 
bradykhesia 
Inhibits dopamine metabolism by selectively 
Benztropine 
trihexyphenidyl 
biperiden 
(antimuscarinic agents) 
Co-administered with L-dopa -Mood changes 
-Xerostomia 
-Visual problems 
-GI disturbances (primarily affecting peristalsis) 
-Glaucoma 
-Prostatic hypertrophy 
-Pyloric stenosis 
4NTIDEPRESSANTS 
dl drugs used to treat depression (called thymoleptics) affect levels and activities of norepinephrine, dopamine, andlor serotonin. 
Category Drugs Mechanism PrecautionsISide Effects 
--- 
Tricyclic antidepressants -Amitriptyline (Elavil) -Block reuptake of monoamine -React with MA0 inhibitors, 
*first line of therapy -Amoxapine (Asendin) transmitters (norepinephrine and direct-acting adrenergic drugs, 
-Desipramine (Norpramin) serotonin) indirect-acting adrenergic drugs, 
-Doxepin (Sinequan) -Also block alpha-adrenergic, ethanol, and other CNS 
histamine, and muscarinic depressants 
receptors 
-Narrow therapeutic index 
-Nortriptyline (Pamelor, Aventyl) -Use caution in manic- 
depressive patients (unmask manic 
- 
Serotonin-reuptake 
inhibitors 
Monoamine oxidase 
inhibitors (MAOI) 
-Fluoxetine (Prozac) 
-Fluvoxamine (Luvox) 
-Nefazodone (Serzone) 
-Paroxetine (Paxil) 
-Sertraline (Zoloft) 
-Trazodone (Desyrel) 
-Venlafaxine (Effexor) 
-1socarboxazid 
-Phenelzine (Nardil) 
-Tranylcypromine (Parnate) 
-Specifically inhibit reuptake of 
serotonin 
--
-Inactivate the MA0 enzymes that 
degrade norepinephrine, 
serotonin, and dopamine 
1 
-React with MA0 inhibitors 
-Avoid tyramine-containing 
foods 
-0rthostatic hypotension 
-Avoid co-administration with 
serotonin-reuptake inhibitors 
Drup I Mechanism Indications I PrecautionsISide Effects 
Pheny toin -Suppression of tonic-clonic and partial 
seizures 
-Initial epileptic treatment 
-Status epilepticus (caused by recurrent 
tonic-clonic) 
-Decreases Na' flux in neurons at resting state 
or during depolarization 3 stabilizes neuronal 
membranes to depolarization and suppresses 
repetitively firing of neurons 
-CNS depression 
-GI disturbances 
-Reversible gingival hyperplasia in children 
-Megaloblastic anemia (interferes with BI2 
metabolism) 
-Fetal hydantoin syndrome 
Carbamazepine 
Phenobarbital 
Primidone 
Valpmic acid 
Ethanosuximide 
Clonazepam 
(benzodiazepine) 
-Partial seizures 
-Tonic-clonic seizures 
-Trigeminal neuralgia 
-Manic-depressive episodes 
-Inhibits Na' channels 4 decreases 
propagation of abnormal impulses in the brain 
3 inhibits repetitive action potentials 
(epileptic focus) 
-Activates GABA-mediated neurons 3 
decreases spread of seizure discharges in 
brain and increases seizure threshold 
-Prodrug (converts to Phenobarbital) 
-Makes electrical activity in the brain more 
regular 
-Enhances GABA 
-Makes electrical activity in the brain more 
regular 
-Prevents seizure spread from epileptogenic 
focus 
-Stupor 
-Coma 
-Respiratory depression 
-Drowsiness 
-Vertigo 
-Ataxia 
-Blurry vision 
-GI disturbances 
-Blood disorders 
-Neurotoxicity 
-Simple partial seizures (not effective for 
complex partial seizures) 
-Recurrent seizures in children (including 
febrile seizures) 
-Recurrent tonic-clonic seizures 
-Adjunctive therapy (not primary treatment 
for any seizure types) 
-  
-Myoclonic seizures 
-Second choice for absence seizures 
-First choice for absence seizures 
-Chronic treatment 
-Nausea and morbilliform rash 
-Sedation, ataxia, nystagmus, vertigo, and acute 
psychotic reactions with chronic use 
-Agitation and confusion with high doses 
-Rebound seizures with discontinuance 
-Similar to phenobarbital 
-Hepatotoxicity 
-Nausea 
-Sedation 
-Ataxia 
-Tremor 
-Rash 
-Alopecia 
-Blood disorders 
-GI disturbances 
-Stevens-Johnson syndrome 
-Blood disorders 
-Sedation 
-Ataxia 
-Dizziness 
-Behavior changes 
IKELETAL MUSCLE RELAXANTS 
urpose: To relieve muscle spasticity or muscle spasm, reduce pain, and increase range of motion 
'ariations: Centrally-acting: Involve stretch reflex arc modification 
Peripherally-acting: Involve disruption of excitation-contraction coupling (direct-acting) 
PrecautionsISide Effects 
Centrally-acting Cyclobenzaprine 
(Flexeril) 
1 disturbances, confusion) 
-Cholinergic effects 
-Hallucinations 
-Weakness 
release of excitatory neurotransmitters -Gastrointestinal disturbances 
-Urinary urgency 
-Confusion 
- 
Peripherally-acting 
(Dantrium) -Insomnia 
-Gastrointestinal disturbances 
Benzodiazepines 1 Diazepam (Valium) Stimulate GABA receptors in CNS and -Drowsiness 
increase pre-synaptic inhibition of -Uncoordinated muscles 
motor neurons 
Acts at level of the brain stem to reduce 
excitatory motor impulses 
Neurotoxin 
-Drowsiness 
-Atropine-like effects (dry mouth, inability 
to accommodate, gastrointestinal 
Botulinum toxin Binds to the receptor sites of motor 
nerve terminals and inhibits 
acetylcholine release 
:ENERAL ANESTHETICS 
he mechanism of general anesthetics is unclear. These agents do not directly affect receptors. They may work by altering lipids in cell 
iembranes. 
PrecautionsISide Effects 
-No analgesic effects 
-Undesired skeletal muscle 
activity 
-Hypotension 
-Decreased respiratory activity 
-Muscle rigidity 
-CNS disturbances 
-
-Extrapyramidal effects 
-Not for use in patients with 
Parkinson's disease 
-Increased sympathetic activity 
-Muscle paralysis 
-CNS disturbances 
Category Mechanism 
, Decrease neural 
activity 
Influence opioid 
receptors 3 decrease 
neural activity 
Drugs Indications 
-Sedation 
-Analgesia prior to 
cardiac surgery 
-Sedation 
-Antiemetic 
-Anticonvulsant 
Sedation in children and 
young adults (does not 
cause circulatory 
depression) 
Benzodiazepines 
Neuroleptic agent 
-Diazepam 
-Lorazepam 
-Midazolam 
-Droperidol + fentanyl 
Opioids 
Influences adrenergic 
receptors 3 
decreases neural 
activity 
Tentany1 
-Morphine 
Decreases neural 
activity 
Dissociative agent -Ketamine 
:ENERAL ANESTHETICS continued 
Drugs Mechanism Indications PrecautionsISide Effects 
Halothane Decreases neural 
activity 
-Potent inhaled anesthetic 
*Drug of choice for use in 
children 
- 
Enflurane 
Isoflurane 
Methoxyflurane 
Nitrous oxide 
Sevoflurane 
-Poor analgesic 
-Bradycardia 
-Cardiac arrhythmias 
-Hypotension 
-Toxic effects (fever, anorexia, nausea & vomiting) 
-Sensitization of heart to catecholamines 
-Decreased cardiac output 
-Hypotension 
-Inhibition of respiratory reflexes 
-Hepatotoxicity 
-Inhaled anesthetic 
-Potent muscle relaxer 
-Inhaled anesthetic 
-Most potent inhaled anesthetic 
-Does not cause relaxation of 
uterus 
--  
-Potent inhaled analgesic 
-Dental procedures 
*Safest inhaled anesthetic 
-- -
-Inhaled anesthetic for children 
Decreases neural 
activity 
Decreases neural 
activity 
Decreases neural 
activity 
Decreases neural 
activity 
Decreases neural 
activity 
-Hepatotoxicity 
-CNS disturbances 
-Slight sensitization of heart to catecholamines 
-Initial decrease in cardiac output 
-Initial hypotension 
-Inhibition of respiratory reflexes 
-Decreased cardiac output 
-Hypotension 
-Initially stimulation respiratory reflexes 
-Not for use in patients with renal failure 
-Poor anesthetic 
-Diffusion hypoxia 
-No known precautionslside effects at this time 
,OCAL ANESTHETICS 
PrecautionsISide Effects Indications Category Mechanism 
Amides 
-CNS and GI disturbances 
-Hypotension 
-Arrhythmias 
-Decreased heart conduction 
-Methemoglobinemia with prilocaine 
-Cardiotoxicity with low doses of 
bupivacaine and ropivacaine 
-Respiratory depression 
-CNS and GI disturbances 
-Arrhythmias 
-Damage of nasal structures with 
vasoconstriction (cocaine) 
-Irreversible nerve damage 
(chloroprocaine) 
-Hypersensitivity 
-Respiratory depression 
-Sedation 
-Nerve block 
-Arrhythmias (lidocaine) 
-1ntracranial hypertension (lidocaine) 
-Epidural anesthesia 
-Dental procedure (mepivacaine, 
prilocaine, etidocaine) 
-Lumbar peridural (etidocaine) 
-1ntraabdominal surgery (etidocaine) 
-Post-operation pain (ropivacaine) 
-Obstetric surgery (ropivacaine) 
Immediate-acting 
-Lidocaine 
Block voltage- 
gated sodium 
Esters 
-Mepivacaine 
-Prilocaine 
Long-acting 
-Etidocaine 
-Bupivacaine 
-Ropivacaine 
channels 3 inhibit 
nerve conduction 
-Nerve block 
-Eye, ear, nose, and throat surgery 
(cocaine) 
-Spinal anesthesia (procaine, tetracaine) 
-Epidural anesthesia 
Short-acting 
-Cocaine 
-Procaine 
-Chlomprocaine 
Immediate-acting 
-Tetracaine 
Block voltage- 
gated sodium 
channels 3 inhibit 
nerve conduction 
LDENOHYPOPHYSEAL HORMONES 
lorrnones released by the anterior pituitary gland (adenohypophysis) 
Hormone Target Function 
Thyroid-stimulating hormone Thyroid gland Stimulates release of thyroid hormones 
(TSH) 
Adrenocorticotropic hormone Adrenal medulla Stimulates release of adrenal hormones 
IACTH) 
Follicle-stimulating hormone Ovaries and testes Stimulates ovarian follicle growth 3 estradiol production 
(FSH] Stimulates sperm production in Sertoli cells 
Luteinizing hormone (LH) Ovaries and testes Stimulates ovulation and maturation of follicle to corpus 
luteum 3 estrogen and progesterone production 
Stimulates testosterone synthesis in Leydig cells 
pp
Stimulates milk production 
Stimulates increased protein synthesis, lipolysis, and 
glycogenesis + increased growth of bone and cartilage 
pp
Increases rate of melanin production in skin 
Prolactin (PRL) 
Growth hormone (GH, 
somatostropin) 
Mammary glands 
Bones and cartilage 
Melanocyte-stimulating hormone 
(MSW 
Melanocy tes 
?HYROID AND ANTITHYROID DRUGS 
[ormones produced by the thyroid gland include T4 (thyroxine, tetraiodothyronine), T3 (triiodothyronine), and calcitonin. 
roduction of these hormones is regulated by levels of thyroid-stimulating hormone (TSH). 
'3 and T4 stimulate carbohydrate metabolism, lipid catabolism, and protein synthesis. 
lalcitonin decreases plasma calcium concentrations. 
Mechanism 
- 
Replenishes T4 
Replenishes T3 
Replenishes T3 and T4 
---- 
Selective uptake by thyroid cells 
results in necrosis 
Inhibits bioconversion of 
inactive T4 to active T3 
--
Inhibits bioconversion of 
inactive T4 to active T3 
Inhibits iodination of tyrosines 
+ decreases levels of T3 and T4 
Drugs Indications PrecautionsISide Effects 
1 
-Caution in metabolic disease patients (diabetes, 
adrenal insufficiency) 
-Similar to levothyroxine 
-Similar to levothyroxine 
-Possible hypothyroidism 
Levothyroxine 
(synthetic T4) 
Levothryronine 
(synthetic T3) 
Liotrix (synthetic 
Tf and T1) 
Radioactive iodine 
(1311) 
Methimazole -Possible hypothyroidism 
-Agranulocytosis 
-Rash 
-Arthralgia 
-Similar to methimazole 
-Possible ulceration of mouth, throat, and other mucous 
membranes 
Hypothyroidism 
Hypothyroidism 
(when levothyroxine 
is ineffective) 
Hypothyroidism 
Hyperthyroidism 
Hyperthyroidism 1 
-Rash 
-Metallic taste 
Propylthiouracil 
(mu) 
Potassium iodide 
solution 
Hyperthyroidism 
Hyperthyroidism 
(including potentially 
fatal thyroid crisis) 
NSULINS 
lsulin is a peptide hormone produced by the P cells of the pancreas. 
- isulin is needed for cellular uptake of glucose from the bloodstream to store as glycogen. 
liabetics lack the ability to produce insulin in sufficient amounts, and may require insulin treatment. 
he duration of action of an insulin agent can be modified by the level of zinc in the preparation. Higher levels of zinc result in longer-acting 
gents by binding to the insulin and slowing its absorption. 
Drugs 
Regular insulin 
Lispro insulin 
Semilente insulin 
Indications 
----
Emergencies (IV administration) 
-
Faster-acting than regular insulin 
(usually used with a longer 
acting agent for glucose control) 
--  
Not suitable for IV 
Onset 
Rapid 
Rapid 
Intermediate 
PrecautionsISide Effects 
-May result in hypoglycemia 
-Lipody strophy 
-Hypersensitivity 
-Similar to regular insulin 
-Similar to regular insulin 
administration 
Isophane insulin -Similar to regular insulin 
administration 
Not suitable in patients with 
diabetic ketoacidosis 
Lente insulin 
(combination of 
semiente and 
ultrlente) 
Ultralente insulin 
Intermediate 
Slow 
Benefit of long-term control that 
ultralente provides, but more 
rapid onset (semilente) 
Long-term control of glucose 
levels 
-Similar to regular insulin 
-Similar to regular insulin 
)RAL HYPOGLYCEMIC AGENTS 
hese agents are used to control glucose levels in Type 2 diabetes mellitus. 
PrecautionsISide Effects Mechanism Category Drugs 
Sulfonylureas -Tolbutamide 
-Chlorpropamide 
-Tolazamide 
-Acetohexamide 
-Glipizide 
-Glyburide 
-Glimepiride 
-Stimulate pancreatic p cells to release 
insulin 
-Decrease levels of glucagon in serum 
-Enhance affinity of receptors to insulin 
Biguanides 
a-Glucosidase 
inhibitor 
Thiazolidinediones 
-Not for use during pregnancy 
-Not for use in patients with hepatic or renal 
insufficiency 
-Sulfonamide cross sensitivity 
-Avoid chlorpropamide in elderly 
-May result in hypoglycemia 
-Metformin 
-Acarbose 
-- 
-Troglitazone 
-Rosiglitazone 
-Similar to sulfonylureas but do not 
stimulate release of insulin 
-Not for use in patients with hepatic or renal 
insufficiency 
-Interference with BIZ absorption with long-term 
use 
-GI disturbances 
-Potential fatal lactic acidosis (but rare) 
-Less hypoglycemia than sulfonylureas 
-Slows the digestion of carbohydrates + 
decreases glucose absorption following 
meals 
-Used alone or in addition to 
-GI disturbances 
-Does not result in hypoglycemia 
-Reduce resistance to insulin, making it 
more effective in liver and skeletal 
muscle 
-Hepatotoxicity 
-Upper respiratory infections 
-Headaches 
-Anemia 
-Edema 
-Weight gain 
-Interfere with oral contraceptives 
-Interfere with P450 system 
STROGENS, PROGESTINS, AND ANDROGENS 
PrecautionsISide Effects 
-Nausea and vomiting 
-Edema 
-Headaches 
-Hypertension 
-Breast tenderness 
Indications 
-Contraception 
-Post-menopausal hormone therapy 
-Osteoporosis 
-Hypogonadism 
Category 
Estrogens 
Progestins 
Androgens 
Drugs 
-Chlorotrianisene 
-Diethilstilbestrol 
-Estradiol 1 
-Estriol 
-Estrone 
-Ethinyl estradiol 
-Mestran01 
-Quinestrol 
Mechanism 
Promote gene 
transcription after binding 
to intracellular receptors 
pppp 
-Contraception 
-Dysfunctional uterine bleeding , 
-Dysmenorrhea 
-Suppression of postpartum 
lactation 
-Endometriosis 
-Endometriocarcinoma 
-Precocious puberty 
-Inadequate androgen secretion 
-Osteoporosis 
-Severe burns 
-Pituitary dwarfism 
-Endometriosis 
-Hydroxyprogesterone 
-Medroxyprogesterone 
-Norethindone 
-Norgestrel 
-Danazol 
-Fluoxymesterone 
-Nandrolone 
-Stanozolol 
-Testosterone cypionate 
-Edema 
-Depression 
-Pulmonary embolism 
-Acne 
-Hinutism 
-Weight gain 
-Jaundice due to lipid 
disturbances 
-Not for use during 
pregnancy 
-Masculinization 
-Acne 
-Impotence 
-Decreased spermatogenesis 
-Gynecomastia 
-Growth disturbances in 
children 
-Lipid disturbances 
Promote protein synthesis 
after binding to 
intranuclear protein 
receptors 
ppppp 
Bind to receptors in target 
cells and stimulate 
synthesis of RNA and 
protein 
LNTI-HYPERTENSIVE AGENTS 
,load pressure is directly related to peripheral vascular resistance and cardiac output. The  goal of treatment for hypertension is to either reduce 
eripheral vascular resistance (through vasodilation) o r  to  decrease cardiac output. 
PrecautionslSide Effects 
-CNS disturbances 
-Decreased libido 
-Disturbances in lipid levels 
-Bronchoconstriction if not PI selective 
-Peripheral vasoconstriction 
-Bradycardia 
-Not for use in patients with second or third degree 
AV block 
- 
-CNS disturbances 
-Dyspnea 
-Nasal congestion 
-Peripheral edema 
-CNS disturbances 
-Decreased sympathetic output throughout the body 
-Postural hypotension, facial flushing, and 
peripheral edema 
-Reflex tachycardia with nefedipine 
-Constipation with verapamil 
-Dry cough (potentiate bradykinins) 
-Hyperkalernia 
-CNS disturbances 
-CNS disturbances 
-Upper respiratory infections 
Mechanism 
-Reduce heart rate and contractility 3 
reduce cardiac output 
-Decrease renin release from kidney 3- 
vasodilation 
Vasodilation 
pppp 
Act within the CNS to inhibit vasomotor 
centers resulting in decreased 
sympathetic output 3 causes 
vasodilation and reduced cardiac output 
pppp 
Relaxation of smooth muscle 3 
vasodilation 
Inhibit angiotensin-converting enzyme 3 
vasodilation 
pppp 
Block angiotensin I1 receptors on blood 
vessels 3 vasodilation 
Drugs 
-Acebut0101 * -Propanolo1 ** 
-Atenolo1 * -Carte0101 ** 
-Betax0101 * -Timolol** 
-Metoprolo1 * -Nadolol * * 
* pl selective 
** non-selective 
---- 
-Prazosin 
-Terazosin 
-Doxazosin 
-Clonidine 
-Methyldopa (drug of choice 
for hypertension during 
pregnancy) 
-Verapamil -Diltiazem 
-Nifedipine -Felodipine 
-1sradipine -Amlodiphe 
-Nicardipine -Nisoldipine 
-Benazepril -Captopril 
-Enalapril -Fosinopril 
-Lisinopril -Moexipril 
-Quinapril -Ramipril 
-Losartan 
-Valsartan 
Category 
p adrenergic 
antagonists 
al adrenergic 
antagonists 
a2 adrenergic 
agonists 
Calcium channel 
I 
blockers 
ACE inhibitors 
Angiotensin I1 
antagonists 
'REATMENT OF CONGESTIVE HEART FAILURE 
ongestive heart failure occurs when the heart is unable to supply the demand of the body. The treatment is aimed at decreasing blood volume, 
 creasing the strength of heart contraction, or reducing the load of the heart by decreasing peripheral resistance. 
Category 
Diuretics 
Drugs 
-Bumetanide 
-Furosemide 
-Hydrochlorothiazide decrease blood volume -CNS & GI disturbances 
-Metolazone 
Mechanism 
Promote secretion of 
sodium and water 3 
Vasodilators 
ACE inhibitors 
Direct smooth muscle relaxants 
PrecautionsISide Effects 
-0rthostatic hypotension 
-Electrolyte imbalances 
-Captopril 
-Enalapril 
-Fosinopril 
-Lisinopril 
-Quinapril 
-Hydralazine 
-1sosorbide 
-Minoxidil 
-Sodium nitroprusside 
Agents that increase contmctilit~~ 
Cardiac glycosides 
P-adrenergic agonists 
Phosphodiesterase inhibitors 
Inhibit angiotensin- 
converting enzyme 
Relax smooth muscle in 
arteries and veins 
-Dry cough (potentiate 
bradykinins) 
-Hyperkalemia 
-CNS disturbances 
-0rthostatic hypotension 
-Milrinone 
-Digitoxin 
-Digoxin 
-Indicated after start of diuretic and 
vasodilation treatment in severe left 
ventricular systolic dysfunction 
-Dobutamine 
-Arnrinone 
Interfere with sodium- 
potassium pump 3 
decrease heart rate and 
increase contractility 
Increase contractility and 
cause vasodilation 
Increase contractility 
-Not for use in diastolic or 
right-sided heart failure 
-Digitalis toxicity 
-GI & CNS disturbances 
-CNS disturbances 
-Cardiac arrhythmias 
-Pulmonary edema 
-GI disturbances 
LNTIARRHYTHMIC DRUGS 
PrecautionsISide Effects 
-Potentially worsens arrhythmias 
-SA and AV block 
-Hyperkalemia 
-GI & CNS disturbances 
-CNS disturbances 
-Potential cardiac arrhythmias 
-Aggrevation of congestive heart failure 
-CNS disturbances 
-Potential ventricular tachycardia 
Class IA 
- 
Mechanism Indications u  -Quinidine 
-Procainamide 
-Disopyramide 
Class I1 
conduction and prolongs action 
potentials 
-AV junction arrhythmias 
-Ventricular tachyarrhythrnias 
Class IB 
-Esmolol 
-Metoprolo1 
-Pindolo1 
-Lidocine 
-Mexilatine 
-Tocainide 
-Propanolo1 -AV node reentry tachycardia -Bronchoconstriction if not P-lselective 
-Peripheral vasoconstriction 
-Bradycardia 
-Not for use in patients with second or third 
degree AV block 
-Prevents arrhythmia -Tachy arrhy thmias 
prolongs duration of action occurrence following -Postural hypotension 
-Atrial fibrillation -Hypotension 
Blocks sodium channels 3 
shortens repolarization and 
decreases duration of action 
potentials 
Blocks P-receptors 3 slows heart 
rate and decreases contractility 
Digitalis 
glycosides 
-Ventricular arrhythmias 
(especially during myocardial 
infarction) 
Class IC -Flecainide 
-Propafenone 
-Tachyarrhythmias 
-Atrial flutter 
-Atrial fibrillation 
-Digitoxin 
-Digoxin 
Blocks sodium channels 3 slows 
conduction and does not affect 
duration of action potentials 
-CNS disturbances 
-Decreased libido 
-Disturbances in lipid levels 
-Refractory ventricular 
arrhythmias 
-Premature ventricular 
contraction 
Interfere with sodium-potassium 
pump 3 decrease heart rate and 
increase contractility 
-Atrial fibrillation 
-Atrial flutter 
-Paroxysmal atrial tachycardia 
-Not for use in patients with diastolic or right- 
sided heart failure 
-Digitalis toxicity 
-GI & CNS disturbances 
LNTIANGINAL AGENTS 
ngina occurs when there is an insufficient supply of blood to the heart. The goal in treating angina is to increase blood supply to heart andlor 
decrease the demand of heart. 
Category 
3rganic nitrates 
demand of heart -Prinzmetal's angina flushing, and tachycardia 
3-Blockers -Propanolo1 Slow cardiac rate and 
-Atenolo1 decreases cardiac output + 
-Metoprolo1 decrease O2 demand of heart pulmonary disease, or 
peripheral vascular disease 
2alcium channel 
-Postural hypotension, facial 
,lockers smooth muscle cells + flushing, and peripheral 
-Diltiazem decrease demand and edema 
increase supply of O2 to 
-Reflex tachycardia with 
heart nefedipine 
I -Constipation with verapamil 1 
Drugs 
-1sosorbide dinitrate 
-Nitroglycerin 
Mechanism 
---Pp 
Cause relaxation of smooth 
muscle + decrease O2 
Indications 
-Stable angina 
-Unstable angina 
PrecautionsISide Effects 
-Headaches 
-Postural hypotension, facial 
LNTICOAGULANTS AND THROMBOLYTICS 
Drugs PrecautionsISide Effects Mechanism Indications 
Anticoagulants 
Heparin -Deep vein thrombosis 
-Pulmonary embolism 
-Prophylaxic treatment for post- 
surgical venous thrombosis 
-Acute myocardial infarction 
-Preferred over other 
anticoagulants in pregnancy 
(does not cross placenta) 
Binds with antithrombin II 3 
indirectly prevents coagulation 
-Hemorrhage 
-Hypersensitivity 
-Thrombocytopenia 
-Not for use in alcoholics 
-Not for use following brain, eye, or spinal cord 
surgery 
-Hemorrhage 
-Interactions with other protein-bound drugs 
-Not for use during pregnancy (teratogenic) 
Warfarin 
Thromboly tics 
Alteplase 
( P A  - tissue type 
plasminogen 
activator) 
Streptokinase 
Anistreplase 
Inhibits vitamin K + produces 
inactive clotting factors 
-Deep vein thrombosis 
-Pulmonary embolism 
-Ischemic heart disease 
-Rheumatic heart disease 
-Patients with artificial heart 
valves 
-Hemorrhage 
-Not for use during pregnancy 
-Not for use in patients with a history of strokes 
-Not for use in patients with metastatic cancer 
-Similar to Alteplase 
-Hypersensitivity 
-Similar to streptokinase 
Activates plasminogen bound to 
fibrin 3 lyses fibrin 
Binds to plasminogen 3 
hydrolyses fibrin plugs and 
degrades fibrinogen, clotting 
factor V, and clotting factor VII 
-Similar to altepase 
-Myocardial infarction 
-Pulmonary embolism 
-Acute ischemic stroke 
-Acute pulmonary embolism 
-Deep vein thrombosis 
-Arterial thrombosis 
-Acute myocardial infarction 
Urokinase 
On-site lysis of blood clot 
Direct enzymatic degradation of 
fibrin and fibrinogen 
-Similar to streptokinase 
-Patients who are sensitive to 
streptokinase 
LNTIHYPERLIPIDEMIC AGENTS 
Category Drugs Mechanism PrecautionsISide Effects 
Bile acid binding resins -Cholestyramine Bind to bile acids and bile salts -GI disturbances 
-Colestipol in small intestine + hepatocytes -Reduced absorption of fat-soluble 
replenish supply by converting vitamins 
cholesterol to bile acids -Interference with absorption of certain 
inhibitors make cholesterol precursors 
-Not for use during pregnancy or 
Fibrateslfibric acid -Gemfibrozil 
derivatives -Clofibrate 
-Fenofibrate synthesis of cholesterol -Malignancy 
-Inflammation of involuntary muscle 
tissue 
1 -Not for use in patients with liver or 
kidney dysfunction 
I 
Niacin (nicotinic acid) -Niacin Inhibits lipid breakdown in 
adipose tissue + reduces supply -GI disturbances 
of cholesterol precursors to liver -Hyperuricemia 
-Liver dysfunction 
-Glucose intolerance 
-Ocular side effects 
IIURETICS 
hese drugs promote urine output by increasing both sodium and water excretion. 
Indications PrecautionsISide Effects Category 
Zarbonic 
snhydrase 
inhibitors 
Loop 
diuretics 
Drugs 
-Acute hypovolemia 
-0totoxicity 
-CNS and GI disturbances 
-Sulfonamide cross sensitivity 
with furosemide 
Mechanism 
-Sulfonamide cross sensitivity 
-Alkaline urine (results in 
metabolic acidosis) 
-Hypokalemia 
-Nephrolithiasis 
-CNS and GI disturbances 
-Transient myopia 
-Aplastic anemia 
-Hypertension 
-Glaucoma 
-Epilepsy 
-Mountain sickness 
-Acetazolamide 
-Methazolamide 
-Dichlorphenamide 
-Furosemide 
-Ethacrynic Acid 
-Bumetanide 
-Torsemide 
-
Inhibit carbonic anhydrase in 
proximal tubule 3 increased 
excretion of HCOi, Na+, and H20 
- -
Inhibit reabsorption of Na+, K+, 
and C1- in ascending loop of Henle 
3 decreased H20 reabsorption 
*most effective diuretics 
-Hypokalemia 
-Hyponatremia 
-Hypocalcemia 
-Hyperuricemia with 
furosemide and ethacrynic 
acid 
-Hypertension 
-Acute pulmonary edema 
-Hypercalcemia 
-Nephrotic syndrome 
-0rthostatic hypotension 
IIURETICS continued 
Jategory 
rhiazide 
iiuretics 
Drugs Mechanism PrecautionsISide Effect Indications 
-Hydrochlorothiazide 
-Chlorthiazide 
-Chlothalidone increased H20 excretion -Nephrotic syndrome 
-1ndapamide 
-Metolazone 
-0rthostatic hypotension -Diabetes insipidus 
-CNS and GI disturbances 
-- 
'otassium- 
.;paring 
j iuretics 
-Spironolactone Inhibit reabsorption of sodium and -Hyperkalemia 
-Amiloride inhibit potassium secretion at the -Hyponatremia -Congestive heart failure 
-Triamterene collecting duct -CNS and GI disturbances -Secondary 
hyperaldosteronism 
Spironolactone 3 aldosterone 
antagonist (often used with loop or 
Amiloride and triamterene thiazide diuretics) 
sodium channel blockers 
filtrate 3 decrease H20 
reabsorption 
-Electrolyte imbalances - I n c r e s e d i n t r a c r a n i a l  
pressure 
-Acute renal failure 
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